EUROPEAN RENAL ASSOCIATION - EUROPEAN DIALYSIS AND TRANSPLANT ASSOCIATION
Services
How to use the platform
Build a poster
MANAGE ORDERS
FAQs
Contact
HOMEPAGE
Virtual Poster Gallery
PrintingOnline for Collection on-site
Accredited Training
DOI - Digital Object Identifier
What is PosterSessionOnline?
How to send your poster
How to visit the Virtual Poster Gallery
How to build a poster
How to reduce a poster to less than 2 Mb
PosterSessionOnline Image Editor
How to build a poster with our templates
How to work with a template
Templates and instructions
Discussion forum -
49th ERA-EDTA Congress
Topic -
Clinical Nephrology - Lab methods and other markers
If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
Poster:
451
Visits:
712
Title:
Increased levels of Interleukin-22 in end stage renal disease and patients and role of dialysis
Authors:
Domenico Santoro ,
Centre:
Dpt Clinical-Experimental of Medicine and Pharmacology
You must be registered to reply or comment.
INCREASED LEVELS OF INTERLEUKIN-22 IN END STAGE RENAL DISEASE AND PATIENTS AND ROLE OF DIALYSIS
Domenico Santoro
Thread initiator
Subspeciality
Reg:
6/10/2010 8:08:00 PM
Comment# 1
I invite healthcare professionals to open debate around the issues raised in my poster, both those relating to research and to clinical practice.
Comment added on 5/8/2012 6:48:00 PM
You must be registered to reply or comment.
Most viewed poster for this congress
Poster:
424
Visits:
2775
Title:
Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Glomerulonephritides: an Immunohystochemical expression analysis
Authors:
Giuseppe Coppolino ,
Centre:
Chair of Nephrology, University Magna Graecia of Catanzaro, Catanzaro, Italy
Poster most viewed in this topic
Poster:
51
Visits:
1514
Title:
A NEW MARKER IN NEPHROLOGY: THE APELIN
Authors:
Antonio Lacquaniti , Donato V, Fazio MR, Lucisano S, Lupica R, Cernaro V, Trimboli D, Buemi M.
Centre:
University of Messina
View Poster Gallery
Back to congress home
Other Congresses
About us
|
Terms and Conditions
|
Special Access